Literature DB >> 32045

Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.

G Nyberg, R Axelsson, E Mårtensson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 32045     DOI： 10.1007/bf00611904

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Binding of thioridazine and some of its metabolites to human serum protein and human albumin.

Authors:  F M Belpaire; F A Vanderheeren; M G Bogaert
Journal:  Arzneimittelforschung       Date:  1975

2.  Serum levels of thioridazine in psychiatric patients and healthy volunteers.

Authors:  E Mårtensson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

3.  Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients.

Authors:  E Mårtensson; G Nyberg; R Axelsson; K Serck-Hansen
Journal:  Curr Ther Res Clin Exp       Date:  1975-11

4.  Serum concentration and elimination from serum of thioridazine in psychiatric patients.

Authors:  R Axelsson; E Mårtensson
Journal:  Curr Ther Res Clin Exp       Date:  1976-02

5.  Studies on serum protein binding of haloperidol.

Authors:  A Forsman; R Ohman
Journal:  Curr Ther Res Clin Exp       Date:  1977-02
  5 in total
  14 in total

1.  Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans.

Authors:  Marion Aubert; Rolf Osterwalder; Björn Wagner; Isabelle Parrilla; Icilio Cavero; Lucette Doessegger; Eric A Ertel
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Concentrations of thioridazine and thioridazine metabolites in erythrocytes.

Authors:  C Svensson; G Nyberg; R Axelsson; E Mårtensson
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Unbound plasma concentrations, total plasma concentrations, and red blood cell concentrations of thioridazine and its main metabolites: an in vitro study.

Authors:  G Nyberg; E Mårtensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

Review 4.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

5.  Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.

Authors:  G Nyberg; E Mårtensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

6.  The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum.

Authors:  F J Rowell; S M Hui; A F Fairbairn; D Eccleston
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

7.  Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.

Authors:  Sandirai Musuka; Shashikant Srivastava; Chandima Wasana Siyambalapitiyage Dona; Claudia Meek; Richard Leff; Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

8.  Plasma protein binding of perazine and amitriptyline in psychiatric patients.

Authors:  M Brinkschulte; H J Gaertner; H W Schied; U Breyer-Pfaff
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.

Authors:  F J Rowell; S M Hui; A F Fairbairn; D Eccleston
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

10.  A unitary mechanism of calcium antagonist drug action.

Authors:  K M Murphy; R J Gould; B L Largent; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.